Nasus Pharma (NSRX) Market Cap (2025 - 2026)
Nasus Pharma (NSRX) market cap from Aug 13, 2025 to Jul 20, 2026. The current Nasus Pharma (NSRX) market cap is $27M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Annual Market Cap change of Nasus Pharma (NSRX)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $27M | -67.10% |
| 2025 | $82M | N/A |
Comparison Nasus Pharma (NSRX) market cap with competitors
Nasus Pharma (NSRX) market cap is $27.14M.
| Ticker | Name | Market Cap | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | $1.03T | +3811074.87% |
| JNJ | Johnson & Johnson | $594.97B | +2192435.18% |
| ABBV | Abbvie Inc | $432.22B | +1592660.45% |
| AZN | Astrazeneca plc | $295.54B | +1089009.79% |
| MRK | Merck & Co Inc | $291.57B | +1074359.66% |
| NVS | Novartis AG | $288.93B | +1064646.37% |
| NVO | Novo Nordisk | $224.93B | +828775.89% |
| AMGN | AMGEN Inc | $193.39B | +712544.26% |
| GILD | Gilead Sciences Inc | $163.57B | +602677.03% |
| PFE | Pfizer Inc | $141.25B | +520422.71% |
| BMY | Bristol-Myers Squibb Company | $119.63B | +440750.77% |
| SNY | Sanofi | $105.20B | +387568.55% |
| GSK | GSK Plc | $104.78B | +386036.91% |
| BIIB | Biogen Inc | $29.03B | +106892.20% |
| GRFS | Grifols SA | $4.91B | +17982.60% |
| OGN | Organon & Company | $3.54B | +12956.81% |
| AMRN | Amarin Corp | $303.37M | +1017.94% |
| SCLX | Scilex Holding Company | $78.29M | +188.50% |
| MIRA | Mira Pharmaceuticals Inc | $39.50M | +45.58% |
| MDCXW | Medicus Pharma Ltd warrant | $19.20M | -29.25% |
| MDCX | MDCorp | $13.93M | -48.65% |